Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 WHO. WHO Global Tuberculosis Report 2018 (2018). www.who.int/tb/publications/global report/gtbr2018 main text.pdf.
  Google Scholar
• 2 Pym AS, Diacon AH, Tang SJ et al. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur. Respir. J. 47(2), 564–574 (2016).
  Medline CASGoogle Scholar
• 3 Pethe K, Bifani P, Jang JC et al. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat. Med. 19(9), 1157–1160 (2013). • A discovery of Q203 is reported.
  Medline CASGoogle Scholar
• 4 Kang S, Kim RY, Seo MJ et al. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent. J. Med. Chem. 57(12), 5293–5305 (2014).
  Medline CASGoogle Scholar
• 5 Jang J, Kim R, Woo M et al. Efflux attenuates the antibacterial activity of Q203 in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 61(7), e02637–e02716 (2017).
  Medline CASGoogle Scholar
• 6 Gao C, Peng C, Shi Y et al. Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis. Sci. Rep. 6, 29717 (2016).
  Medline CASGoogle Scholar
• 7 Makarov V, Manina G, Mikusova K et al. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 324(5928), 801–804 (2009). • Compound BTZ043 for drug-sensitive and extensively drug-resistant TB is disclosed.
  Medline CASGoogle Scholar
• 8 Lade DM, Vagolu SK, Sriram D et al. A facile synthesis and antituberculosis properties of almazole D and its enantiomer. ChemistrySelect 2(3), 1250–1252 (2017).
  CASGoogle Scholar
• 9 Desai NC, Somani H, Trivedi A et al. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents. Bioorg. Med. Chem. Lett. 26(7), 1776–1783 (2016).
  Medline CASGoogle Scholar
• 10 Navarrete-Vázquez G, Molina-Salinas GM, Duarte-Fajardo ZV et al. Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines. Bioorg. Med. Chem. 15(16), 5502–5508 (2007).
  Medline CASGoogle Scholar
• 11 Karabanovich G, Zemanová J, Smutný T et al. Development of 3,5-dinitrobenzylsulfanyl-1,3,4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating Mycobacterium tuberculosis. J. Med. Chem. 59(6), 2362–80 (2016). •• Antimycobacterial activity of 5-pyridyl-1,3,4-oxadiazole is described.
  Medline CASGoogle Scholar
• 12 Ahsan MJ, Samy JG, Khalilullah H et al. Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents. Bioorg. Med. Chem. Lett. 21(24), 7246–7250 (2011).
  Medline CASGoogle Scholar
• 13 Subramanian R, Aidasani D, Bailey K et al. P450-mediated O-demethylated metabolite is responsible for rat hepatobiliary toxicity of pyridyltriazine-containing PI3K inhibitors. Toxicol. Sci. 142(1), 298–310 (2014). • Pyridine mediated hepatotoxicity in rat is described.
  Medline CASGoogle Scholar
• 14 Wang P, Pradhan K, Zhong XB et al. Isoniazid metabolism and hepatotoxicity. Acta Pharm. Sin B. 6(5), 384–392 (2016). •• Highlights the metabolic pathways of isoniazid and discusses their associations with isoniazid-induced liver injury.
  MedlineGoogle Scholar
• 15 Carlson GP. Comparison of the effects of pyridine and its metabolites on rat liver and kidney. Toxicol. Lett. 85(3), 173–178 (1996). • Effects of pyridine and its metabolites on rat kidney and liver were studied.
  Medline CASGoogle Scholar
• 16 Malapati P, Krishna VS, Nallangi R et al. Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors. Eur. J. Med. Chem. 145, 23–34 (2018).
  Medline CASGoogle Scholar
• 17 Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41(5), 1004–1009 (1997).
  Medline CASGoogle Scholar
• 18 Singireesu S, Misra S, Mondal SK et al. Costunolide induces micronuclei formation, chromosomal aberrations, cytostasis, and mitochondrial-mediated apoptosis in Chinese hamster ovary cells. Cell. Biol. Toxicol. 34(2), 125–142 (2018).
  Medline CASGoogle Scholar
• 19 Weinstein MP.Methods For Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically. 8th EditionWayne PA, Clinical and Laboratory Standards Institute, PA, USA (2012).
  Google Scholar
• 20 Lee J, Armstrong DT, Ssengooba W et al. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob. Agents Chemother. 58(1), 11–8 (2014).
  Medline CASGoogle Scholar
• 21 Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).
  MedlineGoogle Scholar
• 22 Lipinski CA, Lombardo F, Dominy BW et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46(1–3), 3–26 (2001).
  Medline CASGoogle Scholar
• 23 Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov. Today Technol. 1(4), 337–341 (2004).
  Medline CASGoogle Scholar
• 24 Lei BF, Wei CJ, Tu SC. Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inha inhibitor. J. Biol. Chem. 275(4), 2520–2526 (2000).
  Medline CASGoogle Scholar
• 25 Singhal P, Dixit P, Singh P et al. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India. Indian J. Med. Res. 143(3), 341–347 (2016).
  Medline CASGoogle Scholar